OliX PharmaceuticalsInc (226950) — Net Asset Momentum
OliX PharmaceuticalsInc (226950) recorded a net asset momentum of 740.8% as of December 2025, with net assets of ₩150.08 Billion KRW. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See 226950 net assets for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
OliX PharmaceuticalsInc Net Asset Momentum (2016–2025)
This chart tracks OliX PharmaceuticalsInc's year-over-year net asset growth across 10 annual reporting periods from 2016 to 2025. The most recent momentum reading is +740.8%, with net assets of ₩150.08 Billion KRW as of December 2025. Check OliX PharmaceuticalsInc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Net Asset History for OliX PharmaceuticalsInc (2016–2025)
The table below shows the complete annual net asset history for OliX PharmaceuticalsInc from 2016 to 2025, covering 10 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 226950 company net worth.
| Year | Net Assets (KRW) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | ₩150.08 Billion | ₩195.37 Billion | ₩45.29 Billion | ▲ +740.8% |
| 2024 | ₩17.85 Billion | ₩71.25 Billion | ₩53.40 Billion | ▼ -64.5% |
| 2023 | ₩50.34 Billion | ₩102.83 Billion | ₩52.49 Billion | ▼ -23.6% |
| 2022 | ₩65.91 Billion | ₩132.65 Billion | ₩66.74 Billion | ▲ +255.9% |
| 2021 | ₩18.52 Billion | ₩86.67 Billion | ₩68.15 Billion | ▼ -59.1% |
| 2020 | ₩45.29 Billion | ₩78.58 Billion | ₩33.29 Billion | ▲ +8.3% |
| 2019 | ₩41.80 Billion | ₩45.21 Billion | ₩3.41 Billion | ▼ -23.9% |
| 2018 | ₩54.94 Billion | ₩55.64 Billion | ₩698.94 Million | ▲ +194.2% |
| 2017 | ₩18.68 Billion | ₩21.64 Billion | ₩2.96 Billion | ▲ +48.7% |
| 2016 | ₩12.56 Billion | ₩15.15 Billion | ₩2.59 Billion | — |